Decoy Therapeutics Inc. Stock-Based Compensation
Decoy Therapeutics Inc. (DCOY) reported Stock-Based Compensation of $419.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $206.18K, a 790.42% increase year-over-year.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $213.04K, a 535.31% increase year-over-year.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $139.52K, a 173.33% increase year-over-year.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $22.85K, a 61.93% decline year-over-year.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $219.06K, a 19.97% decline from fiscal 2024.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $273.73K, a 47.84% decline from fiscal 2023.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $524.84K, a 34.13% decline from fiscal 2022.
- Decoy Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $796.80K, a 42.53% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 4 month | Share-based Payment Arrangement, Noncash Expense 4 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 10 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $206.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $419.22K 10-Q · filed 2026-08-12 | $558.74K derived: sum of 3 quarters · filed 2026-08-12 | $581.59K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2026-03-31 | $213.04K 10-Q · filed 2026-05-08 | $352.57K derived: sum of 2 quarters · filed 2026-05-08 | $375.41K derived: sum of 3 quarters · filed 2026-05-08 | $398.57K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-12-31 | $139.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $162.37K derived: sum of 2 quarters · filed 2026-03-31 | $185.52K derived: sum of 3 quarters · filed 2026-08-12 | $219.06K 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | $22.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $46.00K derived: sum of 2 quarters · filed 2026-08-12 | $79.53K 10-Q · filed 2025-11-14 | $130.58K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-06-30 | $23.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $56.69K 10-Q · filed 2026-08-12 | $107.73K derived: sum of 3 quarters · filed 2026-08-12 | $167.74K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-03-31 | $33.53K 10-Q · filed 2026-05-08 | $84.58K derived: sum of 2 quarters · filed 2026-05-08 | $144.59K derived: sum of 3 quarters · filed 2026-05-08 | $229.76K derived: sum of 4 quarters · filed 2026-05-08 | ||||||||
| 2024-12-31 | $51.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $111.05K derived: sum of 2 quarters · filed 2026-03-31 | $196.22K derived: sum of 3 quarters · filed 2026-03-31 | $273.73K 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | $60.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $145.18K derived: sum of 2 quarters · filed 2025-11-14 | $222.69K 10-Q · filed 2025-11-14 | $308.06K derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $85.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $162.68K 10-Q · filed 2025-08-12 | $248.05K derived: sum of 3 quarters · filed 2025-08-12 | $360.71K derived: sum of 4 quarters · filed 2025-08-12 | ||||||||
| 2024-03-31 | $77.51K 10-Q · filed 2025-05-14 | $162.88K derived: sum of 2 quarters · filed 2025-05-14 | $275.54K derived: sum of 3 quarters · filed 2025-05-14 | $399.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | $85.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $198.03K derived: sum of 2 quarters · filed 2025-03-21 | $321.49K derived: sum of 3 quarters · filed 2025-03-21 | $524.84K 10-K · filed 2025-03-21 | ||||||||
| 2023-09-30 | $112.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $236.12K derived: sum of 2 quarters · filed 2024-11-14 | $439.46K 10-Q · filed 2024-11-14 | $584.97K derived: sum of 4 quarters · filed 2024-11-14 | ||||||||
| 2023-06-30 | $123.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $326.80K 10-Q · filed 2024-08-09 | $472.31K derived: sum of 3 quarters · filed 2024-08-09 | $610.18K derived: sum of 4 quarters · filed 2024-08-09 | ||||||||
| 2023-03-31 | $203.34K 10-Q · filed 2024-05-13 | $348.85K derived: sum of 2 quarters · filed 2024-05-13 | $486.72K derived: sum of 3 quarters · filed 2024-05-13 | $686.25K derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | $145.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $283.37K derived: sum of 2 quarters · filed 2024-03-22 | $482.90K derived: sum of 3 quarters · filed 2024-03-22 | $796.80K 10-K · filed 2024-03-22 | ||||||||
| 2022-09-30 | $137.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $337.39K derived: sum of 2 quarters · filed 2023-11-09 | $651.30K 10-Q · filed 2023-11-09 | $797.19K derived: sum of 4 quarters · filed 2023-11-09 | ||||||||
| 2022-06-30 | $199.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $513.43K 10-Q · filed 2023-08-10 | $659.32K derived: sum of 3 quarters · filed 2023-08-10 | $789.64K derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | $313.90K 10-Q · filed 2023-05-11 | $459.79K derived: sum of 2 quarters · filed 2023-05-11 | $590.11K derived: sum of 3 quarters · filed 2023-05-11 | $737.57K derived: sum of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | $145.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $276.21K derived: sum of 2 quarters · filed 2023-03-27 | $423.67K derived: sum of 3 quarters · filed 2023-03-27 | $559.04K 10-K · filed 2023-03-27 | ||||||||
| 2021-09-30 | $130.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $277.77K derived: sum of 2 quarters · filed 2022-11-10 | $413.15K 10-Q · filed 2022-11-10 | $582.88K derived: sum of 4 quarters · filed 2022-11-10 | ||||||||
| 2021-06-30 | $147.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $282.83K 10-Q · filed 2022-08-05 | $452.57K derived: sum of 3 quarters · filed 2022-08-05 | $530.91K derived: sum of 4 quarters · filed 2022-08-05 | ||||||||
| 2021-03-31 | $135.38K 10-Q · filed 2022-05-12 | $305.11K derived: sum of 2 quarters · filed 2022-05-12 | $383.46K derived: sum of 3 quarters · filed 2022-05-12 | $416.36K derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | $169.73K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $248.08K derived: sum of 2 quarters · filed 2022-03-25 | $280.98K derived: sum of 3 quarters · filed 2022-03-25 | $319.39K 10-K · filed 2022-03-25 | ||||||||
| 2020-09-30 | $78.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $111.25K derived: sum of 2 quarters · filed 2021-11-04 | $149.66K 10-Q · filed 2021-11-04 | $321.56K derived: sum of 4 quarters · filed 2021-11-04 | ||||||||
| 2020-06-30 | $32.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $71.31K 10-Q · filed 2021-08-05 | $243.21K derived: sum of 3 quarters · filed 2021-08-05 | $781.49K derived: sum of 4 quarters · filed 2021-08-05 | ||||||||
| 2020-03-31 | $38.41K 10-Q · filed 2021-05-12 | $210.31K derived: sum of 2 quarters · filed 2021-05-12 | $748.59K derived: sum of 3 quarters · filed 2021-05-12 | $754.62K derived: sum of 4 quarters · filed 2021-05-12 | ||||||||
| 2019-12-31 | $171.90K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $710.18K derived: sum of 2 quarters · filed 2021-03-18 | $716.21K derived: sum of 3 quarters · filed 2021-03-18 | $751.62K 10-K · filed 2021-03-18 | ||||||||
| 2019-09-30 | $538.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $544.31K derived: sum of 2 quarters · filed 2020-11-12 | $579.72K 10-Q · filed 2020-11-12 | $557.90K derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | $6.03K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-12 | $41.44K 10-Q · filed 2020-08-12 | $433.52K 10-Q · filed 2019-07-17 | $19.62K derived: sum of 3 quarters · filed 2020-08-12 | -$1.35M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-03-31 | $35.41K 10-Q/A · filed 2020-05-15 | $220.97K 10-Q · filed 2019-05-01 | $13.59K derived: sum of 2 quarters · filed 2020-05-15 | -$1.35M derived: sum of 3 quarters · filed 2020-05-15 | -$842.57K derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | -$21.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | -$1.39M derived: sum of 2 quarters · filed 2020-03-23 | -$877.98K derived: sum of 3 quarters · filed 2020-03-23 | $30.96K 10-K · filed 2020-03-23 | $1.94M 10-K · filed 2019-03-06 | |||||||
| 2018-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$856.16K derived: sum of 2 quarters · filed 2019-11-12 | $52.78K 10-Q · filed 2019-11-12 | $1.70M 10-Q · filed 2018-11-05 | $1.01M derived: sum of 4 quarters · filed 2019-11-12 | |||||||
| 2018-06-30 | $510.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17 | $1.42M 10-Q · filed 2019-07-17 | $2.37M derived: sum of 3 quarters · filed 2019-07-17 | $3.38M derived: sum of 4 quarters · filed 2019-07-17 | ||||||||
| 2018-03-31 | $908.94K 10-Q · filed 2019-05-01 | $1.86M derived: sum of 2 quarters · filed 2019-05-01 | $2.87M derived: sum of 3 quarters · filed 2019-05-01 | $3.94M derived: sum of 4 quarters · filed 2019-05-01 | ||||||||
| 2017-12-31 | $952.29K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $1.96M derived: sum of 2 quarters · filed 2019-03-06 | $3.03M derived: sum of 3 quarters · filed 2019-03-06 | $4.22M 10-K · filed 2019-03-06 | ||||||||
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $2.08M derived: sum of 2 quarters · filed 2018-11-05 | $3.27M 10-Q · filed 2018-11-05 | $4.47M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.26M 10-Q · filed 2018-08-01 | $3.47M derived: sum of 3 quarters · filed 2019-03-06 | $5.33M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-03-31 | $1.19M 10-Q · filed 2018-05-02 | $2.39M derived: sum of 2 quarters · filed 2019-03-06 | $4.26M derived: sum of 3 quarters · filed 2019-03-06 | $6.24M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2016-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $3.07M derived: sum of 2 quarters · filed 2019-03-06 | $5.05M derived: sum of 3 quarters · filed 2019-03-06 | $6.57M 10-K · filed 2019-03-06 | ||||||||
| 2016-09-30 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $3.85M derived: sum of 2 quarters · filed 2017-11-06 | $5.37M 10-Q · filed 2017-11-06 | $7.07M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $3.51M 10-Q · filed 2017-08-02 | $5.21M derived: sum of 3 quarters · filed 2018-03-07 | $6.72M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-03-31 | $1.52M 10-Q · filed 2017-05-03 | $3.22M derived: sum of 2 quarters · filed 2018-03-07 | $4.73M derived: sum of 3 quarters · filed 2018-03-07 | $6.37M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2015-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $3.21M derived: sum of 2 quarters · filed 2018-03-07 | $4.85M derived: sum of 3 quarters · filed 2018-03-07 | $6.60M 10-K · filed 2018-03-07 | ||||||||
| 2015-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $3.15M derived: sum of 2 quarters · filed 2016-11-02 | $4.89M 10-Q · filed 2016-11-02 | |||||||||
| 2015-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.39M 10-Q · filed 2016-08-03 | ||||||||||
| 2015-03-31 | $1.75M 10-Q · filed 2016-05-04 | |||||||||||
| 2014-12-31 | $1.46M 10-K · filed 2017-03-08 | |||||||||||
| 2014-06-30 | $673.26K 10-Q · filed 2015-11-04 | $320.68K 10-Q · filed 2015-08-05 | ||||||||||
| 2014-03-31 | $11.94K 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |